冀衡医药
(002742)
| 流通市值：17.92亿 | | | 总市值：23.40亿 |
| 流通股本：5.24亿 | | | 总股本：6.84亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 334,385,519.52 | 240,714,752.19 | 141,899,006.39 | 899,848,459.7 |
| 营业总成本 | 359,554,520.02 | 257,766,525.34 | 150,188,902.55 | 1,215,169,034.85 |
| 其他经营收益 | | | | |
| 营业利润 | -22,032,758.85 | -15,991,802.03 | -8,059,010.29 | -410,804,925.99 |
| 利润总额 | -21,976,787.74 | -16,163,078.06 | -8,195,419.42 | -436,704,005.6 |
| 净利润 | -26,937,740.97 | -20,723,540.22 | -8,705,479.41 | -458,788,954.47 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | -19,517,324.15 |
| 综合收益总额 | -26,937,740.97 | -20,723,540.22 | -8,705,479.41 | -478,306,278.62 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 332,384,249.88 | 317,621,995.26 | 337,260,281.89 | 393,497,528.11 |
| 非流动资产: | | | | |
| 非流动资产合计 | 764,628,899.77 | 777,721,330.06 | 788,472,616.16 | 802,261,484.78 |
| 资产总计 | 1,097,013,149.65 | 1,095,343,325.32 | 1,125,732,898.05 | 1,195,759,012.89 |
| 流动负债: | | | | |
| 流动负债合计 | 251,742,494.68 | 243,022,609 | 260,456,385.33 | 321,043,035.15 |
| 非流动负债: | | | | |
| 非流动负债合计 | 632,911,149.73 | 633,747,010.33 | 634,684,745.92 | 635,418,731.53 |
| 负债合计 | 884,653,644.41 | 876,769,619.33 | 895,141,131.25 | 956,461,766.68 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 141,757,403.95 | 148,242,087.28 | 160,307,267.93 | 168,380,544.2 |
| 股东权益合计 | 212,359,505.24 | 218,573,705.99 | 230,591,766.8 | 239,297,246.21 |
| 负债和股东权益合计 | 1,097,013,149.65 | 1,095,343,325.32 | 1,125,732,898.05 | 1,195,759,012.89 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 119,156,953.58 | 84,692,632.37 | 43,409,618.03 | 772,862,930.08 |
| 经营活动现金流出小计 | 191,989,373.47 | 151,618,122.26 | 106,022,247.63 | 798,735,401.97 |
| 经营活动产生的现金流量净额 | -72,832,419.89 | -66,925,489.89 | -62,612,629.6 | -25,872,471.89 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 139,400 | 41,000 | 41,000 | 4,363,043.64 |
| 投资活动现金流出小计 | 1,964,899.24 | 1,656,899.24 | 1,040,249.24 | 39,356,920.39 |
| 投资活动产生的现金流量净额 | -1,825,499.24 | -1,615,899.24 | -999,249.24 | -34,993,876.75 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 50,000,000 | 50,000,000 | 50,000,000 | 301,136,027.76 |
| 筹资活动现金流出小计 | 53,035,745.39 | 51,535,806.55 | 50,333,663.82 | 186,339,879.19 |
| 筹资活动产生的现金流量净额 | -3,035,745.39 | -1,535,806.55 | -333,663.82 | 114,796,148.57 |
| 汇率变动对现金及现金等价物的影响 | - | - | 0 | -4,758,186 |
| 现金及现金等价物净增加额 | -77,693,664.52 | -70,077,195.68 | -63,945,542.66 | 49,171,613.93 |
| 期末现金及现金等价物余额 | 26,970,100 | 34,586,568.84 | 50,547,358.09 | 104,663,764.52 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -70,077,195.68 | - | 49,171,613.93 |